Safety of metamizole analgesic therapy in patients with dyspepsia syndrome: A case report

Anam, Khoirul and Widiyawati, Rina and Sugesti, Tita and Pristantiningtyas, M. Hari and Dharma, Herya Putra and Muchlis, Muhammad and Pratama, Jainuri Erik and Setiadi, Antonius Adji Prayitno and Gondokesumo, Marisca Evalina (2023) Safety of metamizole analgesic therapy in patients with dyspepsia syndrome: A case report. Jurnal Teknologi Laboratorium, 12 (2). pp. 66-70. ISSN 2338-5634; E-ISSN 2580-0191

PDF Marisca Evalina Gondokesumo_Safety of metamizole analgesic therapy.pdf Download (1MB)

Abstract

The selection of drugs in patients who have experienced dyspepsia syndrome needs to be studied for its use. Non-steroidal anti-inflammatory drugs (NSAIDs) are a class of drugs that are effective in controlling various inflammatory conditions and treating inflammatory symptoms such as pain but are limited in their use in patients with dyspepsia. We report case of patients with metamizole NSAIDs during three days of hospitalization with a diagnosis of dyspepsia. Other side effects such as cardiovascular, neurological disorders and agranulocytosis can also occur with the use of metamizole. There were no side effects that exacerbated dyspepsia symptoms in patients or other side effects during the three days of using metamizol. It can be concluded that short-termmetamizole therapy is safe for use in patients with dyspeptic syndrome. Concomitant use with gastric acid blocking agents such as H2 receptor antagonists may also reduce the effects of gastrointestinal disturbances.

Item Type:	Article
Uncontrolled Keywords:	Metamizole, Gastrointestinal, Adverse effect, Dyspepsia
Subjects:	R Medicine > RS Pharmacy and materia medica
Divisions:	Faculty of Pharmacy > Department of Pharmacy
Depositing User:	Ester Sri W. 196039
Date Deposited:	02 Jan 2024 07:32
Last Modified:	02 Jan 2024 07:52
URI:	http://repository.ubaya.ac.id/id/eprint/45570

Actions (login required)

View Item